Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, 90095, USA.
Department of Obstetrics & Gynecology, David Geffen School of Medicine At UCLA, Los Angeles, CA, 90095, USA.
Malar J. 2020 Aug 5;19(1):280. doi: 10.1186/s12936-020-03351-0.
Maternal malarial infection leads to poor perinatal outcomes, including low birth weight from preterm delivery and/or fetal growth restriction, particularly in primigravidas. In placental malaria, Plasmodium falciparum-infected red blood cells cause an inflammatory response that can interfere with maternal-fetal exchange, leading to poor growth. The type I interferon (IFN-I) pathway plays an immunomodulatory role in viral and bacterial infections, usually by suppressing inflammatory responses. However, its role in placental malaria is unknown. This study examines the cytokine responses in placental tissue from subsets of malaria-infected and uninfected women, and attempts to correlate them with particular birth outcomes.
40 whole placental biopsy samples were obtained from pregnant women at least 16 years of age recruited to a larger prospective chemoprevention trial against malaria. These were patients at Tororo District Hospital in Uganda, an area of high malaria endemicity where approximately 40% of women have evidence of malaria infection at delivery. They were regularly followed at a local clinic and monitored for fever, with blood smears performed then and at time of delivery to diagnose malaria infection. Placenta biopsies were taken for histological diagnosis of placental malaria, as well as quantitative PCR analysis of genes in the IFN-I pathway (IFN-β, IL-10 and MX-1). Parameters such as infant birth weight and gestational age were also recorded.
Histological analysis revealed placental malaria in 18 samples, while 22 were found to be uninfected. RT-PCR analysis showed a four-fold increase in IFN-β and IL-10 expression in multigravidas with placental malaria when compared to gravidity-matched, uninfected controls. This effect was not observed in primigravidas. Interestingly, linear regression analysis showed a positive association between IFN-β levels and higher birth weights (β = 101.2 g per log2-fold increase in IFN-β expression, p = 0.042). This association was strongest in primigravidas with placental malaria (β = 339.0, p = 0.006).
These results demonstrate differential regulation of the IFN-I pathway in placental malaria according to gravidity, with the greatest anti-inflammatory response seen in multigravidas. The association between IFN-β levels and higher birth weight also suggests a protective role for IFN-I against fetal growth restriction in placental malaria.
母体疟疾感染可导致围产期结局不良,包括早产和/或胎儿生长受限导致的低出生体重,尤其是初产妇。在胎盘疟疾中,感染疟原虫的红细胞引起炎症反应,可能干扰母婴交换,导致生长不良。I 型干扰素(IFN-I)途径在病毒和细菌感染中发挥免疫调节作用,通常通过抑制炎症反应。然而,其在胎盘疟疾中的作用尚不清楚。本研究检查了疟疾感染和未感染妇女胎盘组织中的细胞因子反应,并试图将其与特定的出生结局相关联。
从参加大型疟疾化学预防试验的至少 16 岁的孕妇中获得了 40 个完整胎盘活检样本。这些患者来自乌干达托罗罗区医院,该地区疟疾高度流行,约 40%的产妇分娩时存在疟疾感染证据。她们在当地诊所定期随访,并监测发热情况,然后进行血涂片以诊断疟疾感染。进行胎盘活检以进行胎盘疟疾的组织学诊断,以及 IFN-I 途径(IFN-β、IL-10 和 MX-1)基因的定量 PCR 分析。还记录了婴儿出生体重和胎龄等参数。
组织学分析显示 18 个样本存在胎盘疟疾,而 22 个样本未感染。与匹配的未感染对照组相比,多产妇胎盘疟疾中 IFN-β 和 IL-10 的表达增加了四倍。初产妇中未观察到这种影响。有趣的是,线性回归分析显示 IFN-β 水平与较高的出生体重之间存在正相关(β=每增加 1 个 IFN-β 表达的对数倍增加 101.2g,p=0.042)。这种关联在胎盘疟疾的初产妇中最强(β=339.0,p=0.006)。
这些结果表明,根据孕次,胎盘疟疾中 IFN-I 途径的调节存在差异,多产妇中观察到最大的抗炎反应。IFN-β 水平与较高出生体重之间的关联也表明 IFN-I 在胎盘疟疾中对胎儿生长受限具有保护作用。